Copyright © 1990 by the European Society of Cardiology.
© 1990 The European Society of Cardiology
Is echocardiography an adequate method to evaluate left ventricular hypertrophy regression?
Hôpital Cardiologique du Haut-Lévêque, Centre Hospitalier et Universitaire de Bordeaux Pessac, France
Address for correspondence: Docteur Philippe Gosse, Hôpital Cardiologique du Haut-Lévêque, avenue de Magellan, 33604 Pessac, France
M mode echocardiography is certainly an adequate method to evaluate left ventricular hypertrophy (LVH) regression in hypertensive patients, provided that some important conditions are fulfilled. Left ventricular mass assessment can be made only with non-distorted ventricles, as usually encountered in non-complicated hypertensive patients. The main problem is to limit all sources of variability for serial measuremennts and all sources of subjectivity in their interpretation. So, we propose some guidelines that should be useful when designing and completing such studies. Two-dimensional echocardiography offers the potential advantage of allowing assessment of left ventricular mass even when the left ventricle b far from its usual shape. However, a standardization of methods and studies of its reproducibility are still required before this method could be recommended in studies of LVH regression.
Key Words: Left ventricular hypertropy regression echocardiography
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. G. Myerson, H. E. Montgomery, M. J. World, and D. J. Pennell Left Ventricular Mass: Reliability of M-Mode and 2-Dimensional Echocardiographic Formulas Hypertension, November 1, 2002; 40(5): 673 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Myerson, N. G. Bellenger, and D. J. Pennell Assessment of Left Ventricular Mass by Cardiovascular Magnetic Resonance Hypertension, March 1, 2002; 39(3): 750 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jeren-Strujic, V. Raos, T. Jeren, S. Horvatin-Godler, and B. Jeren-Strujic Morphologic and Functional Changes of Left Ventricle in Dialyzed Patients After Treatment with Recombinant Human Erythropoietin (r-HuEPO) Angiology, February 1, 2000; 51(2): 131 - 139. [Abstract] [PDF] |
||||

